Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Cyclophosphamide 2040 Radiotherapy 1854 Cisplatin 1820 Carboplatin 1530 Gemcitabine 1432 Paclitaxel 1289 Bevacizumab 1267 Docetaxel 1200 pembrolizumab 1196 Oxaliplatin 1157 Capecitabine 1140 Fluorouracil 1059 Dexamethasone 971 Rituximab 918 Nivolumab 908 Magnetic Resonance Spectroscopy 858 Etoposide 839 Doxorubicin 823 Drug Therapy 789 Radiosurgery 774 Irinotecan 774 Cytarabine 736 fludarabine 714 Leucovorin 674 Lenalidomide 608 fludarabine phosphate 564 Temozolomide 552 Filgrastim 540 Radiation 539 Cetuximab 535

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × dynorphin-converting endopeptidase × Clear all

NCT07583160 2026-05-13

YS247

Changhai Hospital

Phase 1 Enrolling by invitation

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡